HepaHope —We Deliver A Better Life
HepaHope develops and commercializes therapeutic and diagnostic technologies to improve patient health.
We strive to improve the quality of life and life expectancy of liver failure patients with our Bio-Artificial Liver device.
We aim to create a new paradigm shift in diagnostics.
HepaHope News
- 01.12.09 - HepaHope signs agreement with HepaHope Korea to manufacture and distribute the Chemosensitivity Testing System and BioTester™
- 11.04.08 - HepaHope presents research data at San Francisco AASLD conference
- 08.22.08 - HepaHope signs an agreement with Quintiles for its clinical trial program